Skip to main content

Table 1 Patient and tumor characteristics

From: Patient-reported outcomes version of the common terminology criteria for adverse events and quality-of-life linear analogue self-assessment in breast cancer patients receiving radiation therapy: single-institution prospective registry

  n = 331
Age, years (range) 60 (29–87)
BMI (range) 26.8 (17.3–50.7)
ECOG  
 0 219 (66%)
 1 108 (33%)
 2 4 (1%)
Laterality  
 Right 163 (49%)
 Left 168 (51%)
Histology  
 Invasive ductal 283 (85%)
 Invasive lobular 13 (4%)
 Mixed 5 (2%)
 Other 30 (9%)
Grade  
 1 71 (21%)
 2 148 (45%)
 3 111 (34%)
 Not reported 1 (< 1%)
pT stage  
 T0 25 (8%)
 Tis 52 (16%)
 T1 169 (51%)
 T2 63 (19%)
 T3 21 (6%)
 Not reported 1 (< 1%)
Nodal status  
 Negative 211 (64%)
 Positive 87 (26%)
 Not reported 33 (10%)
ER positive 271 (82%)
PR positive 255 (77%)
HER2 positive 33 (10%)
TNBC 27 (8%)
  1. BMI, body mass index; ECOG, Eastern Cooperative Oncology Group; ER, estrogen receptor; PR, progesterone receptor; TNBC, triple negative breast cancer